Lapatinib Intermediate CAS 231278-84-5 Ịdị ọcha>98.0% (HPLC)
Aha Chemical | 5-[4-[3-Chloro-4- (3-Fluorobenzyloxy) anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde |
Ụdị okwu | Lapatinib Intermediate 3;5-[4-[3-Chloro-4-[(3-Fluorophenyl) methoxy] phenyl] amino]-6-Quinazolinyl]-2-Furancarboxaldehyde;5-[4- ((3-Chloro-4- ((3-Fluorobenzyl) oxy) phenyl) amino) quinazolin-6-yl] -2-Furaldehyde |
Nọmba CAS | 231278-84-5 |
Ọnọdụ Ahịa | N'ọkwa, Mpụta Ihe ruru Tọn |
Usoro ihe omimi | C26H17ClFN3O3 |
Ibu molekụla | 473.90 |
Ebe Na-agbaze | 225.0 ruo 235.0 ℃ |
Njupụta | 1.407±0.06 g/cm3 |
Ntụgharị uche | 1.694 |
COA & MSDS | Dị |
Mmalite | Shanghai, China |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | Icha mmirimmiri ruo ntụ ntụ siri ike na-acha odo odo |
Ụzọ ịdị ọcha / nyocha | > 98.0% (HPLC) |
Ebe Na-agbaze | 225.0 ~ 235.0 ℃ |
Ọnwụ na ihicha | <1.00% |
Ihe fọdụrụ na mgbanye | <0.50% |
Mgbakọta adịghị ọcha | <2.00% |
Ọla dị arọ (dị ka Pb) | <20ppm |
Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
Ojiji | Ọkara nke API (CAS 388082-77-7) |
ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri
5-[4-[3-Chloro-4- (3-Fluorobenzyloxy) anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde (CAS: 231278-84-5) bụ etiti API (CAS 388082-77-7) ).(CAS 388082-77-7) bụ ọgwụ ezubere iche maka ọrịa ara ara nke British GlaxoSmithKline Co. Ọ bụ tyrosine kinase inhibitor nke nwere ike igbochi ọrụ tyrosine kinase nke ọma nke ndị na-anabata ihe na-eto eto epidermal mmadụ 1 na 2 (ErbB1, ErbB2).Ọ nwere ike ime ihe n'ụzọ dị iche iche, na-ahụ na mkpụrụ ndụ kansa ara enweghị ike ịnata akara uto.Ọ na-egbochi intracellular EGFR (ErbB-1) na HER2 (ErbB-2) saịtị ATP, na-egbochi tumor cell phosphorylation na activation, igbochi ala-usoro akara ngosi site homogeneity na heterogeneity nke EGFR (ErbB-1) na HER2 (ErbB-1) dimerization.